Additionally, miR-21-5p raises the level of LC3II/I by boosting the ubiquitination of Sirtuin7 (SIRT7) through ubiquitin-specific peptidase 42 (USP42), promoting deterioration and resistance to sorafenib in HCC cells [121]. The gene discussed is USP42; the disease is hepatocellular carcinoma.